Skip to main content
. 2014 Jan 16;63(2):483–493. doi: 10.2337/db13-0954

Figure 4.

Figure 4

Si (top panel) and DITotal (bottom panel) during saline infusion and during exendin-9,39 infusion in the post-RYGB subjects (left panel) and in control subjects (right panel). *P < 0.05.